Notably, killing efficacy of patient-derived UniCAR T cells upon antigen-specific redirection with the dual-specific anti-CD123-CD33 TM was comparable between T cells from healthy donors and patients with AML (Figure 2f). The gene discussed is CD33; the disease is acute myeloid leukemia.